1st Course Capital

1st Course Capital is a Redwood City fund built around a single conviction: that the food system is one of the largest and most under-capitalized opportunities in early-stage venture, and that the line between food and health is collapsing. The firm is not a healthcare fund in the conventional sense, but its consumer-wellness work touches metabolic health, nutrition, and the broader category of preventive lifestyle interventions where physicians increasingly play a role.

The stated thesis centers on companies rebuilding the food system from supply chain through consumer experience, with consumer wellness sitting as a natural adjacency. That means the firm will look at metabolic-health platforms, GLP-1-adjacent nutrition products, condition-specific food brands, and the kinds of clinically informed consumer offerings that physician founders sometimes spin out of clinics. It does not mean they will fund pure clinical software, diagnostics, or therapeutics. The fund does not publish a deep portfolio list, so founders should treat the wellness adjacency as directional rather than as a checklist.

Stage focus runs from seed through Series A, which makes 1st Course a fit for founders who have a product in market, early commercial traction, and a clear story about repeat purchase or clinical adherence. Check size is undisclosed but consistent with a focused early-stage fund: expect them to lead or co-lead seeds and participate in Series A rounds. Geography is United-States-centric, with a strong California gravity given the Bay Area location and the food industry concentration there.

The team is small and has not been published in detail on the fund site, so diligence will be relationship-driven and partner-led rather than process-heavy. That can be an advantage if you are a clinician-founder who can speak credibly to both consumer behavior and clinical outcomes.

Approach 1st Course when your company sits squarely at the food-and-health intersection: a metabolic-health platform with a nutrition core, a condition-specific food brand with clinical evidence, a supply-chain play that improves access to medically meaningful food, or a wellness service with a defensible health angle. Pre-revenue founders without a thesis on consumer pull will have a harder time. Warm introductions from food-system operators, consumer-health founders in the Bay Area, or other early-stage VCs in the wellness category are the most reliable path in. Do not approach if you are building a regulated digital therapeutic or a clinical AI tool; even if there is a wellness story, the fund’s center of gravity is the food system, not the clinic. Reach out when you have at least a beta product, a few months of consumer data, and a clear point of view on why food is the right wedge into health for your specific patient population.